IDSA AMR Guidance|AMR 1.0 & 2.0|Learn with Dr Akshatha| ESBL AmpC CRE CRAB DTR pseudomonas treatment

แชร์
ฝัง
  • เผยแพร่เมื่อ 5 ก.ย. 2024
  • A brief overview of IDSA AMR 1.0 & 2.0
    Treatment guidance of ESBL AmpC CRE CRAB DTR pseudomonas

ความคิดเห็น • 24

  • @nasrullahmalik2713
    @nasrullahmalik2713 2 ปีที่แล้ว +1

    Impressed by the reasoning you give for starting or stopping antibiotics. Good teaching methodology of question-answer pattern. In a few slides the question disappears quickly, it should not.

  • @RajRaj-lb8fc
    @RajRaj-lb8fc ปีที่แล้ว

    Based on version 2 of guidance. The laboratory needs to be able to detect AmpC. Kindly describe the method of detection for practice use in the lab.

  • @vatoloco2116
    @vatoloco2116 ปีที่แล้ว

    Thank you so so much doc...much needed lecture on beta lactamases..I was searching for quite sometime for literature and videos on beta lactamases until I found you.

  • @mehvashhaider2484
    @mehvashhaider2484 2 ปีที่แล้ว +1

    beautifully and comprehensively covered. extremely beneficial.

  • @RajRaj-lb8fc
    @RajRaj-lb8fc ปีที่แล้ว

    Well done doctor . Kindly give us updates on CLSI GUIDELINES on ESBL/ Amp C and CRE FOR laboratory use in practical fashion. Clinicians expect to deem other 3GC’s antibiotics resistant when automated machines give ESBL PRODUCEr among enterobacterales. Help us understand the current thinking please.

  • @nawafnawaf2538
    @nawafnawaf2538 3 หลายเดือนก่อน

    Thank you sooooo much

  • @shafiasworld1144
    @shafiasworld1144 ปีที่แล้ว

    Great job!!can you please make a video on the new 2023 IDSA guidance on amr

  • @kevinfitzgerald7474
    @kevinfitzgerald7474 ปีที่แล้ว

    How about Lyme disease which is a resistant OspA bacteria. What causes borrelia to be a resistant bacteria. It's not antibiotics. There are other things within the lyme borrellia causing resistance.

  • @hashimaachi5265
    @hashimaachi5265 9 หลายเดือนก่อน

    Ma'am cefepime is a 4th generation only not 5th G

  • @medicalmicrobiology7917
    @medicalmicrobiology7917 ปีที่แล้ว

    Excellent, helpful

  • @hashimaachi5265
    @hashimaachi5265 9 หลายเดือนก่อน

    Can you please provide note pdf

  • @chaitanyasoorya
    @chaitanyasoorya 2 ปีที่แล้ว +1

    Super class madam

  • @SanjeevKumar-yk8xr
    @SanjeevKumar-yk8xr 2 ปีที่แล้ว

    Mam, what is role of carbapenem in treatment of Amp C infections?

  • @aruntc4535
    @aruntc4535 2 ปีที่แล้ว

    very good presentation mam , can you pls send the ppt ?

  • @SanjeevKumar-yk8xr
    @SanjeevKumar-yk8xr 2 ปีที่แล้ว

    Mam, what is role of aminoglycosides long duration therapy in treatment of ESBL and AmpC?

    • @LearnwithDrAksh
      @LearnwithDrAksh  2 ปีที่แล้ว

      Long duration coz f Nephrotoxicity not preferred... Can b used for shorter duration in UTI... Single dose is sufficient fr uncomplicated UTI... For BSI can b used as a part of combination therapy...

    • @SanjeevKumar-yk8xr
      @SanjeevKumar-yk8xr 2 ปีที่แล้ว

      @@LearnwithDrAksh Thanks

  • @nerdydragon.12
    @nerdydragon.12 ปีที่แล้ว

    can we discuss real clinical scenario with u

    • @LearnwithDrAksh
      @LearnwithDrAksh  ปีที่แล้ว

      Yes surely... Mail me - will give you my contact no.

    • @nerdydragon.12
      @nerdydragon.12 ปีที่แล้ว

      @@LearnwithDrAksh thanks